Literature DB >> 21157915

The relationship between aquaporin-4 expression and blood-brain and spinal cord barrier permeability following experimental autoimmune encephalomyelitis in the rat.

Xiang-Nan Huang1, Wei-Zhi Wang, Jin Fu, Hua-Bing Wang.   

Abstract

Aquaporin 4(AQP4) is a water channel protein strongly expressed in the central nervous system in perimicrovessel astrocyte foot processes, the glia limitans, and ependyma. Expression of AQP4 is highest at the blood-brain barrier and blood-spinal cord barrier, supporting its critical function in material transport across these structures. Recently, presence of the anti-aquaporin-4 antibody in sera has been used as an important diagnostic tool for neuromyelitis optica, suggesting a potential role in central nervous system inflammation. The aim of the present study was to examine AQP4 protein expression in the cerebellum and spinal cord from rats with experimental autoimmune encephalomyelitis. By western blot analysis, AQP4 expression increased during experimental autoimmune encephalomyelitis development, and peaked at onset (lumbar enlargement) or climax (cerebellum) of neurological signs of experimental autoimmune encephalomyelitis. There was also a faster and more pronounced increase in permeability in the cerebellar blood-brain barrier and the lumbar enlargement blood-spinal cord barrier consistent with AQP4 expression, which was manifested by increased Evans Blue leakage and reduced tight junction protein expression. In conclusion, aquaporin upregulation may be involved in the development of inflammation in the acute phase of experimental autoimmune encephalomyelitis, and may correlate with damage to central nervous system barrier function. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21157915     DOI: 10.1002/ar.21286

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  7 in total

1.  Aquaporin-4 deficiency attenuates acute lesions but aggravates delayed lesions and microgliosis after cryoinjury to mouse brain.

Authors:  Wen-Zhen Shi; Chun-Zhen Zhao; Bing Zhao; Xiao-Liang Zheng; San-Hua Fang; Yun-Bi Lu; Wei-Ping Zhang; Zhong Chen; Er-Qing Wei
Journal:  Neurosci Bull       Date:  2012-02       Impact factor: 5.203

2.  Hypercholesterolemia induces short-term spatial memory impairments in mice: up-regulation of acetylcholinesterase activity as an early and causal event?

Authors:  Eduardo Luiz Gasnhar Moreira; Jade de Oliveira; Daiane Fátima Engel; Roger Walz; Andreza Fabro de Bem; Marcelo Farina; Rui Daniel S Prediger
Journal:  J Neural Transm (Vienna)       Date:  2013-10-29       Impact factor: 3.575

3.  Aggravated inflammation and increased expression of cysteinyl leukotriene receptors in the brain after focal cerebral ischemia in AQP4-deficient mice.

Authors:  Wen-Zhen Shi; Chun-Zhen Zhao; Bing Zhao; Qiao-Juan Shi; Li-Hui Zhang; Yan-Fang Wang; San-Hua Fang; Yun-Bi Lu; Wei-Ping Zhang; Er-Qing Wei
Journal:  Neurosci Bull       Date:  2012-11-06       Impact factor: 5.203

Review 4.  Aquaporin 4: a player in cerebral edema and neuroinflammation.

Authors:  Andrew M Fukuda; Jerome Badaut
Journal:  J Neuroinflammation       Date:  2012-12-27       Impact factor: 8.322

5.  miR-320a affects spinal cord edema through negatively regulating aquaporin-1 of blood-spinal cord barrier during bimodal stage after ischemia reperfusion injury in rats.

Authors:  Xiao-Qian Li; Bo Fang; Wen-Fei Tan; Zhi-Lin Wang; Xi-Jia Sun; Zai-Li Zhang; Hong Ma
Journal:  BMC Neurosci       Date:  2016-02-05       Impact factor: 3.288

6.  Spinal cord swelling in patients with cervical compression myelopathy.

Authors:  Naohiro Tachibana; Takeshi Oichi; So Kato; Yusuke Sato; Hiroyuki Hasebe; Shima Hirai; Yuki Taniguchi; Yoshitaka Matsubayashi; Harushi Mori; Sakae Tanaka; Yasushi Oshima
Journal:  BMC Musculoskelet Disord       Date:  2019-06-14       Impact factor: 2.362

Review 7.  The history of neuromyelitis optica. Part 2: 'Spinal amaurosis', or how it all began.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2019-12-28       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.